Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
9(29%)
Results Posted
18%(3 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
3
10%
Ph phase_3
1
3%
Ph not_applicable
25
81%
Ph phase_1
2
6%

Phase Distribution

2

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution31 total trials
Phase 1Safety & dosage
2(6.5%)
Phase 2Efficacy & side effects
3(9.7%)
Phase 3Large-scale testing
1(3.2%)
N/ANon-phased studies
25(80.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.0%

17 of 20 finished

Non-Completion Rate

15.0%

3 ended early

Currently Active

9

trials recruiting

Total Trials

31

all time

Status Distribution
Active(11)
Completed(17)
Terminated(3)

Detailed Status

Completed17
Recruiting9
Not yet recruiting2
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
31
Active
9
Success Rate
94.4%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (6.5%)
Phase 23 (9.7%)
Phase 31 (3.2%)
N/A25 (80.6%)

Trials by Status

completed1755%
not_yet_recruiting26%
recruiting929%
terminated13%
withdrawn26%

Recent Activity

Clinical Trials (31)

Showing 20 of 31 trialsScroll for more
NCT07395882Not Applicable

A New Model to Induce Itch and Inflammation

Not Yet Recruiting
NCT07255092Not Applicable

Mechanisms Underlying the Nocibo Effect of Contagious Itch. in Both Histaminergic and Nonhistaminergic Itch

Not Yet Recruiting
NCT07247695Not Applicable

Mechanisms Underlying the Placebo Effect in Both Histaminergic and Non-histaminergic Itch

Recruiting
NCT07122973Not Applicable

Topographical Distribution of Itch and Pain Receptors

Recruiting
NCT06503510Not Applicable

Role of Interleukin-13 Pathways on Pain and Itch Sensitivity

Recruiting
NCT06154824Not Applicable

Repetitive Applications of Pruritogens and Effects of a Cutaneous-induced Pain Stimulation on Nonhistaminergic Itch Perception

Completed
NCT06245564Not Applicable

Effect of Ketamine, Amitriptyline and Their Combination on Itch

Completed
NCT04676763Not Applicable

Substance P Challenge in Healthy Participants

Completed
NCT06470737Not Applicable

Investigation of Corticospinal Excitability Aspects of Itch and Pain

Completed
NCT03943407Not Applicable

Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch

Withdrawn
NCT06503523Not Applicable

The Effects of Performing a Motor Imagery Task on Cortical Excitability During Acute Experimental Muscle Pain and Acute Itch

Recruiting
NCT06328543Not Applicable

Itch Sensation Induced by Multiple Applications of Pruritogens (temporal Summation)

Recruiting
NCT06081946Not Applicable

Investigation of the Effects of Sleep Fragmentation on Itch and Pain Sensitivity

Recruiting
NCT06340438Not Applicable

Investigate the Relationship Between Catastrophizing and the Perception of Itch Intensity in Healthy Individuals

Recruiting
NCT06328530Not Applicable

Itch Sensation Induced by Simultaneous Application of Pruritogens (Spatial Summation)

Recruiting
NCT06081998Not Applicable

Investigation of the Effects of Sleep Deprivation on Itch and Pain Sensitivity

Recruiting
NCT04058054Not Applicable

Skin Prick Test of KeraStat® Cream

Completed
NCT04554888Not Applicable

Characterization of New Human Models of Non-histaminergic Itch and Their Interaction With the TRPM8 Receptor

Completed
NCT04700007Not Applicable

Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)

Completed
NCT04588532Not Applicable

Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch

Completed

Drug Details

Intervention Type
OTHER
Total Trials
31